Navigation Links
EndoSphere Inc. Receives Patent for Obesity Treatment
Date:6/15/2011

COLUMBUS, Ohio, June 15, 2011 /PRNewswire/ -- EndoSphere Inc., a medical technology company that holds 23 U.S. and international issued and pending patents, announced today that the U.S. Patent and Trademark Office has issued the company a patent covering the use of its endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes.

U.S. Patent number 7,931,693 titled "Method and Apparatus for Reducing Obesity" describes a noninvasive device that uses the body's natural physiology to regulate appetite and satiety among other potential uses.

"This strong initial patent position, in combination with significant clinical interest, makes EndoSphere an attractive partner in the rapidly growing fields of interventional gastroenterology and obesity treatments," commented James McKinley, EndoSphere CEO.  

Kenneth Binmoeller, M.D., EndoSphere's co-founder and the technology's inventor, commented, "EndoSphere's inventions respond to the urgent need for a less invasive, safer and more physiologic treatment for the growing problem of obesity worldwide."

"Treating obesity is the first target for our technology, the first of several major medical applications for which we plan to develop and commercialize products," added McKinley.

EndoSphere Inc. completed an oversubscribed Series A funding in June 2011.

About EndoSphere Inc.

EndoSphere Inc. is a medical technology company founded in 2006.  The company develops and commercializes devices including the SatiSphere™ duodenal insert, which treats one of the most critical healthcare issues in the world today: obesity and its co-morbidities.  EndoSphere holds 23 U.S. and international issued and pending patents.  EndoSphere is a portfolio company of Broadline Capital, a global private equity investment firm.  For more information, please visit <
'/>"/>

SOURCE EndoSphere Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EndoSphere Inc. Announces Pivotal Financing Led by Broadline Capital
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Research and ... of the  "2015 Strategies in the Global ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... of the orthopedics market, including forecasts for ... categories. , ,In addition, the report presents ...
(Date:5/27/2015)... Research and Markets ( ... the  "North America Mammography Market - Growth, ...  report to their offering.      ... detailed type of imaging that customs a ... mammography exam, called a mammogram, is used ...
(Date:5/27/2015)... 27, 2015 OpportunityAnalyzer: Sepsis - Opportunity Analysis ... suffer from a series of diverse complications arising from ... blood or tissues, which cause a rapidly progressing hyperactive ... rates near 50% depending on disease severity. The syndrome ... of the global marketplace, which for the purposes of ...
Breaking Medicine Technology:Global Orthopedics Market Strategies 2015 2North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4
... 2012   CANTEL MEDICAL CORP. (NYSE:CMN) announced today ... presenting at the Needham & Company, LLC  14th Annual ... AM ET on Wednesday, January 11, 2012 at The ... session immediately following the presentation. In addition, Mr. Krakauer ...
... 4, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), ... focused on cardiac and vascular surgery, announced today that ... position of Vice President, Research and Development; and David ... President, Market Development Surgical Adhesives and Starch Medical Relations.  ...
Cached Medicine Technology:CryoLife Enhances Management Team with Promotions 2CryoLife Enhances Management Team with Promotions 3CryoLife Enhances Management Team with Promotions 4CryoLife Enhances Management Team with Promotions 5
(Date:5/27/2015)... California (PRWEB) May 27, 2015 Western ... marked by a few historic firsts -- and one ... the Pasadena Civic Center marked the first time the ... the first time a Graduate College of Biomedical Sciences ... of the Pacific (COMP). , The university’s fifth and ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 “We are ... Schuller, MD, executive vice president and vice president of ... grant makes possible allows us to provide comprehensive care ... our community.” , SSCHC provides clinical care and behavioral ... 35,000 people in 2014, many of whom took advantage ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 While hair ... hair loss, a new pilot study conducted by a ... Surgery (ISHRS) has found hair follicle grafting can help ... research was partially funded by ISHRS, which offers research ... to hair restoration. , In the past decade, ...
(Date:5/27/2015)... 2015 NOVAtime Technology, Inc. ( ... solutions for enterprise organizations, announced today that SanMar ... automate its time, attendance and point tracking processes ... the United States. , Family-owned since 1971, ... 21 retail, private label, and mill brands. SanMar ...
(Date:5/27/2015)... ABILENE, Texas (PRWEB) May 27, 2015 ... addition of three FDA-approved dermal filler treatments in Abilene, ... designed to reduce the appearance of glabellar lines, better ... lines. Belotero Balance® is designed to treat smoker’s ... mouth to the chin, while Radiesse® improves the appearance ...
Breaking Medicine News(10 mins):Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:Sixteenth Street Community Health Centers To Expand Primary Care and Behavioral Health Services Through $1 Million Grant From Aurora's Better Together Fund 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2
... The California Alliance for Inclusive Communities (CAIC) has recently ... 374. They join the majority of state and national ... is an advocacy group that works on behalf of ... ,Just as a new national AP/Ipsis poll ...
... new report released today by the Pharmaceutical Research and ... testing 277 medicines for two of the three leading ... and stroke. The medicines are currently in clinical trials ... (FDA). ,'Heart disease and stroke are still ...
... advent of a possible new blockbuster drug and greater ... drug addictions, global sales of smoking cessation and ... little over $1.1 billion in 2005 to more than ... Addiction Treatments: A World Market Analysis, a new study ...
... effects on cardiometabolic risk factors beyond those expected from ... may not be due to the drug itself, reports ... Therapeutics Bulletin (DTB). ,Advertisements for rimonabant ... that an estimated 50% of the effects on ...
... year the last day of May is celebrated as the ... World Health Organization to wag a warning finger at the ... This year the focus is on 100% smoke free ... to tobacco. There is also an effort to highlight the progress ...
... smokers today by declaring the site of the Beijing Olympics a ... Olympic venues and restaurants," The Telegraph quoted Zhang Jianshu, a city ... issue can raise has already been seen at the stadiums for ... by security guards to stop construction workers taking a cigarette break ...
Cached Medicine News:Health News:More Than 270 Medicines in Testing for Heart Disease and Stroke 2Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2Health News:Stop Smoking, Start Living: World No Tobacco Day 2Health News:Stop Smoking, Start Living: World No Tobacco Day 3Health News:Stop Smoking, Start Living: World No Tobacco Day 4Health News:China Bans Smoking at Olympics 2
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
For the qualitative detection of group A Streptococcal antigen from throat swabs...
Medicine Products: